LivsMed Expands its ArtiSential Portfolio

LivsMed has officially released the first 5mm wristed articulating laparoscopic instrument series on the market, ArtiSential 5. 
 
Introduced in 2019, the first-generation ArtiSential is a line of single-use laparoscopic instruments with double-jointed end effectors controlled by an ergonomic grip. The end effectors move in perfect synchronization with the surgeon’s natural wrist and hand movements, offering the precision of robotic surgical platforms without the high cost. Additionally, ArtiSential provides tactile feedback, allowing surgeons to apply the right pressure to delicate tissue—something robotic systems cannot achieve. The new ArtiSential 5—which is 40% smaller than the existing 8mm line—offers significant advantages for both surgeons and patients.
 
ArtiSential 5 instruments are lighter and exceptionally well-balanced, making them easier to handle, according to the company. Additionally, these instruments offer greater flexibility, as they can be used in any port during laparoscopic or robotic procedures. When used in port assists during robotic surgery, ArtiSential 5 instruments can potentially reduce procedure costs, LivsMed executives claim.
 
The ArtiSential 5’s smaller size can also improve visibility at the surgical site depending on surgery type and approach angle.
 
For patients, the use of a smaller trocar to accommodate the 5mm instrument means a smaller incision, which can result in reduced pain, faster healing, and minimal scarring.
 
LivsMed Inc. is a medical device company developing minimally invasive surgical technology. It was founded in South Korea by Dr. Jung Joo Lee, who envisioned a new paradigm of laparoscopic procedures where articulating technology is available to all surgeons. The ArtiSential line was introduced to the Korean market in 2018 and the United States the following year. ArtiSential received the Red Dot Design Award and recognition from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).